Riparian Pharmaceuticals is discovering therapeutics to reverse endothelial dysfunction and provide a new approach to vascular health.

Riparian Pharmaceuticals

Viva BioInnovator operates as the investment division of Viva Biotech Holdings, focusing on identifying and supporting early-stage biotech companies through investment and incubation.

Viva BioInnovator

Riparian Pharmaceuticals | 434 followers on LinkedIn. Discovering therapeutics to improve vascular health | Riparian Pharmaceuticals is an early stage biotechnology company employing innovative models of vascular pathophysiology to discover novel therapeutics

In nature, the riparian zone is a unique rich ecosystem created through the interaction of a river with its banks. In the human body, moving blood, or hemodynamics, similarly interacts with the walls of blood vessels generating unique biological activity. This very interaction, between hemodynamics and the vascular wall, is a critical and unexplored determinant of vascular health.

CEO, President, Co-founder at Riparian Pharmaceuticals

Metric
Company Name	Riparian Pharmaceuticals	Viva BioInnovator
Symbol
MSH ID	COM:RIPARIANPHARMA	COM:VIVABIOINNOVATOR
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Financial Services & Finance
Industry	Pharmaceuticals	Biotechnology
Country	US	HK
Stage	Series A
Employee Count
Website	riparianpharma.com	vivabioinnovator.com
LinkedIn	riparian-pharmaceuticals-inc-	viva-bioinnovator
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		176
Web Traffic Growth		-0.72
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

RIPA

COM:RIPARIANPHARMA

Riparian Pharmaceuticals

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue